BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
Recognizing our leadership in AI, data analytics and Real-World Data.
BC Platforms in the press: Bio-IT World highlights our view on the role of AI in helping the European Health Data Space deliver secure, harmonized and high-value research.
We welcome Keith Collier as Chief Product Officer and Michele Lichtenfield as EVP and Head of Global Marketing.
We join BRECISE, a major cancer research initiative advancing biomarker development to improve diagnosis, treatment and personalized care across Europe.